Hopp til hovedinnhold

Pyoderma gangrenosum

Pyoderma gangrenosum er en sjelden, men alvorlig sårsykdom i huden. I minst halvparten av tilfellene foreligger en underliggende systemisk sykdom.

Sist revidert:

QR
Del pasientinformasjon

Den ligger åpent tilgjengelig på NHI.no sammen annen relevant informasjon

https://nhi.no/sykdommer/hud/sar-hudskader-bitt/pyoderma-gangrenosum/ 

Hva er pyoderma gangrenosum?

Årsak

Symptomer

Undertyper

Diagnosen

Behandling

Prognose

Vil du vite mer?

Kilder

Referanser

Dette dokumentet er basert på det profesjonelle dokumentet Pyoderma gangrenosum. Referanselisten for dette dokumentet vises nedenfor.

  1. Schadt C. Pyoderma gangrenosum: Pathogenesis, clinical features, and diagnosis. UpToDate, last updated Jul 23, 2020. UpToDate 
  2. Jackson JM. Pyoderma gangrenosum. Medscape, last updated Sep 05, 2018. emedicine.medscape.com 
  3. Burian EA, Karlsmark T, Fogh K, Bech R. Ugeskr Laeger. 2021;183(24):V12200949. PubMed 
  4. Alavi A, French LE, Davis MD et al. Pyoderma gangrenosum: an update on pathophysiology, diagnosis and treatment. Am J Clin Dermatol 2017;18:355-72. PubMed 
  5. George C, Deroide F, Rustin M. Pyoderma gangrenosum – a guide to diagnosis and management. Clin Med (Lond) 2019;19:224-8. PubMed 
  6. Ruocco E, Sangiuliano S, Gravina AG, et al. Pyoderma gangrenosum: an updated review. J Eur Acad Dermatol Venereol 2009; 23:1008. PubMed 
  7. Ahronowitz I, Harp J, Shinkai K. Etiology and management of pyoderma gangrenosum: a comprehensive review. Am J Clin Dermatol 2012; 13:191. PubMed 
  8. Ashchyan HJ, Butler DC, Nelson CA, et al. The Association of Age With Clinical Presentation and Comorbidities of Pyoderma Gangrenosum. JAMA Dermatol 2018; 154: 409-13. pmid:29450453 PubMed 
  9. Reichrath J, Bens G, Bonowitz A, Tilgen W. Treatment recommendations for pyoderma gangrenosum: an evidence-based review of the literature based on more than 350 patients. J Am Acad Dermatol 2005; 53: 273-83. PubMed 
  10. Schadt C. Pyoderma gangrenosum: Treatment and prognosis. UpToDate, last updated Aug 18, 2020. UpToDate 
  11. Ormerod AD, Thomas KS, Craig FE, et al. Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial. BMJ. 2015 Jun 12;350:h2958. doi: 10.1136/bmj.h2958.
  12. Thomas KS, Ormerod AD, Craig FE, et al. Clinical outcomes and response of patients applying topical therapy for pyoderma gangrenosum: A prospective cohort study. J Am Acad Dermatol 2016; 75:940. PubMed 
  13. Binus AM, Qureshi AA, Li VW, Winterfield LS. Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients. Br J Dermatol 2011; 165:1244. PubMed 
  14. Turner RB, Emer JJ, Weill M, et al. Rapid resolution of pyoderma gangrenosum after treatment with intravenous cyclosporine. J Am Acad Dermatol 2010; 63:e72. PubMed 
  15. Brooklyn TN, Dunnill MG, Shetty A, et al. Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial. Gut 2006; 55:505. Gut 
  16. Brooklyn TN, Dunnill MG, Shetty A, Bowden JJ, Williams JD, Griffiths CE, et al. Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial. Gut 2006; 55: 505-9. Gut